About
Shift Bioscience develops therapeutic solutions targeting cellular aging to reverse age-driven diseases, focusing on anti-fibrotic siRNA treatments and a proprietary target discovery platform.
Explore Shift Bioscience's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.